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Abstract
We report a case of unexplained recurrent stupor for which, given 
the current knowledge and the lack of easily available diagnostic 
tools, we were unable to reach a definite diagnosis. In the patient the 
syndrome was associated with an ominous prognosis. Worldwide 
accepted and easily available proceeding method is needed to 
manage patients with recurrent stupor for which a toxic origin may 
be supposed.
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Introduction
Since 1992 the existence of a clinical entity characterized 
by unexplained recurrent hypersomnolence, named Idiopathic 
Recurrent Stupor (IRS), and has been an interesting matter of 
debate [1]. Recently, Plazzi et al [2] stated that, at present, IRS has 
to be considered an unproven and questionable entity and it is 
therefore mandatory, before making this diagnosis, to perform 
sophisticated toxicological tests to rule out the presence of exogenous 
benzodiazepines (BZDs). Unfortunately these tests cannot be easily 
done in the setting of routine clinical practice, and in some patients 
with unexplained recurrent hypersomnia the diagnosis of IRS might 
be, mistakenly, still supposed.
Case Report
We studied a 76-year old man who was admitted to our hospital 
in March 2011, after having been found unconscious at home. He 
was partially aroused only by vigorous tactile stimuli. Glasgow Coma 
Scale was 6; ocular examination showed a slight bilateral miosis 
with preserved but torpid pupillary reflex; oculo-cephalic reflex was 
present. Vital parameters and brain CT scan were normal. Blood and 
urine samples for routine and toxicological tests were collected. An 
electroencephalogram (EEG) showed a widespread 13-18 Hz fast 
activity, prominent over the frontal regions, on an otherwise normal 
waking background rhythm. When vocally and manually stimulated, 
or during eye opening, the patient’s EEG showed a paradoxical 
reaction with a temporary return of alpha-like frequency. Sample 
tests were clear from toxic substances (benzodiazepines, barbiturates, 
tricyclic antidepressants, amphetamine, cocaine, alcohol, opioids, and 
cannabinoids). Lumbar puncture was performed and cerebrospinal 
fluid (CSF) chemical analysis was unremarkable. He gradually and 
spontaneously recovered from the stupor after three days. On day 
four, he was totally oriented and able to behave completely normal, 
although he was not able to recall anything happened during the 
previous event. Repeated EEGs were normal and he was discharged 
in healthy condition.
After the first episode he came to our emergency department 
six more times, nearly every two months, in the same state of 
stupor. Brain magnetic resonance imaging (MRI), single photon 
emission tomography, brain angio-MRI, cardiological check, 
abdominal ultrasound, interictal one-night polysomnography 
recording, electromyography study, immunology-wide screening 
and neuropsychological assessment were normal. In each occasion 
blood and urine tests were repeated, but failed to detect any hint of 
substance abuse.
For the first time, in our clinical experience, we thought to be 
facing a case of possible endozepine stupor, a condition characterized 
by episodes of stupor purportedly linked to elevated serum level of the 
endogenous benzodiazepine receptor ligand, endozepine-4 [1,3,4]. In 
the light of negative exam results and based on the clinical and EEG 
features, which totally resembled those seen in IRS, from the second 
episode we decided to try flumazenil. What happened was a sudden, 
although temporary (5-10 minutes), change in the patient’s EEG, 
which returned to a normal alpha rhythm (Figure 1), and a prompt 
return of consciousness. We repeated flumazenil each time he came 
to our hospital in the stupor condition since it was the only effective 
therapy we could offer him at that time. Moreover, we decided to 
check the patient’s blood and cerebral spinal fluid samples for the 
presence of endozepine-4. This was done through an experimental 
lab in Emilia-Romagna where a Liquid chromatography-Mass 
Spectrometry (LC-MS) detecting method was available, according 
to what suggested by Cortelli et al. [4]. Disappointingly, this exam 
turned out negative for endozepine. Unfortunately, the labs in our 
region were not able to perform a more sophisticated assessment 
other than traditional Gas-Chromatographic-Mass-Spectrometric 
(GCMS) for ruling out exogenous benzodiazepine receptor agonists. 
Indeed, more advanced recommended methodic such as LC-MS or 
High Performance Liquid chromatography-electrospray tandem 
mass spectrometry (HPLC-MS-MS) are mostly used for research 
purpose.
Although some peculiar features in the family history pointed 
to a possible Munchausen syndrome by proxy, no concrete evidence 
came out even after the patient and his family had been questioned 
different times. The patient became more and more frustrated for 
the condition which we could not explain or stop and he died after 
committing suicide. 
Discussion and Conclusions
We want to point out the difficulty you might find while evaluating 
people with unexplained IRS, since, as already warned, there are a 
lot of toxicological substances such as triazolam, bromazepam, 
lorazepam as well as zopiclone, zolpidem and zalepon that are very 
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Figure 1: EEG monitoring before and after flumazenil injection.
A. Widespread low voltage (10-15 μV), fast frequency activity (13-16 Hz), prominent over the frontal regions; B. 6 minutes after flumazenil injection. 
Reappearance of alpha-like frequency background rhythm (8-12 Hz).
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difficult to detect using conventional techniques such as immunoassay 
screening, GCMS and HPLC [5,6]. Thus, although this issue has 
been going on for the last two decades, still now, unrecognized toxic 
recurrent hypersomnia cannot be easily disclosed, in clinical practice, 
by routine available diagnostic tools. Therefore, a worldwide accepted 
and feasible proceeding method seems required for clarifying 
situations that might lead to important legal repercussion, potentially 
involving patient’s safety and clinicians’ responsibility and, as in our 
patient, to an ominous prognosis.
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